The Tim Ferriss Show
The Tim Ferriss Show

#824: What Most Has My Attention Right Now — Credible (vs. Bogus) Vagus Nerve Stimulation

Kevin J. Tracey, MD is president and CEO of the Feinstein Institutes for Medical Research at Northwell Health, a pioneer of vagus nerve research and author of the recent book, The Great Nerve: The New Science of the Vagus Nerve and How to Harness Its Healing Reflexes. This episode is brought to you

Featured Speakers

Tim Ferriss Host

Topics Discussed

Episode Summary

Executive Summary: Tim Ferriss interviews Dr. Kevin J. Tracy about the vagus nerve, inflammation, and bioelectronic medicine, centering on newly FDA-approved vagus nerve stimulation for rheumatoid arthritis. They explore how the brain can suppress inflammation via the inflammatory reflex, why some chronic diseases may be driven by dysregulated cytokines, and how implants, auricular stimulation, breathing, cold exposure, and other interventions may modulate this system.

Main Topics: FDA approval of vagus nerve stimulation for rheumatoid arthritis (Priority: 5/5): The conversation opens with the announcement that SetPoint Medical received FDA approval for a device that stimulates the vagus nerve to treat rheumatoid arthritis, validating decades of research on the inflammatory reflex and bioelectronic medicine. What the vagus nerve is and how it works (Priority: 5/5): Dr. Tracy explains the anatomy and function of the vagus nerves as two large bidirectional nerve networks connecting the brain to organs throughout the chest and abdomen, emphasizing that they are not a single nerve but hundreds of thousands of fibers. Inflammation, cytokines, and the inflammatory reflex (Priority: 5/5): The discussion defines inflammation, explains cytokines such as TNF, IL-1, and IL-6, and describes how vagus nerve signaling can reduce excessive inflammatory responses without fully suppressing immunity. Clinical evidence and patient stories (Priority: 4/5): Kelly Owens and Ulf Andersen are used as vivid examples of dramatic improvements in severe inflammatory disease and depression, illustrating the potential real-world impact of vagus nerve-based therapies. Limits, risks, and mechanism-specific caution (Priority: 4/5): Ferriss and Tracy discuss why not all vagus nerve stimulation claims are valid, why mechanism matters, and why broad suppression of inflammation can be dangerous when done with biologics but not necessarily with VNS. Noninvasive and indirect stimulation methods (Priority: 4/5): The episode covers auricular stimulation, cervical TENS devices, focused ultrasound, breathing, meditation, cold exposure, and exercise as possible ways to influence vagal tone or related pathways, while distinguishing them from direct implanted stimulation. Memory, engrams, and future directions (Priority: 4/5): Tracy describes emerging work suggesting inflammation can form brain engrams and that specific cytokine-related neural networks may someday be targeted to treat chronic pain, depression, and other inflammatory conditions.

Key Arguments: The vagus nerve is a major brain-body communication pathway that can suppress inflammation through an evolutionarily conserved inflammatory reflex. Bioelectronic medicine aims to treat disease by targeting neural circuits rather than only molecules, using devices to modulate specific physiological pathways. Vagus nerve stimulation reduces cytokine production without causing the broad immunosuppression seen with anti-TNF or other biologics. Many chronic diseases, including rheumatoid arthritis, Crohn’s disease, depression, and possibly neurodegeneration, may be worsened by inflammation. Clinical case studies, while not definitive alone, can reveal meaningful therapeutic signals and justify larger trials. Not all devices marketed as vagus nerve stimulators truly stimulate the vagus nerve; direct stimulation requires either an implanted electrode or focused ultrasound. Some benefits of auricular or cervical stimulation may arise through indirect neural pathways, but mechanisms remain uncertain and require rigorous study. Inflammation may be sensed by the brain and encoded as neural networks or engrams, potentially explaining persistent symptoms and recurrence. Lifestyle practices such as sleep, exercise, meditation, breathing, and cold exposure may support vagal function and reduce inflammatory burden, but they are not cures for serious disease.

Data Points: FDA approval: 1 new approval - SetPoint Medical received FDA approval for a vagus nerve stimulation device to treat rheumatoid arthritis. Vagus nerve fibers per side: 100,000 fibers - Dr. Tracy explains that each vagus nerve contains about 100,000 fibers. Total vagus fibers: 200,000 fibers - Combined left and right vagus nerves contain roughly 200,000 fibers. Direction of signaling: 80% afferent / 20% efferent - Most vagus fibers carry information from the body to the brain, while a smaller portion carries signals from the brain to organs. Inflammation reduction: about 70% - Vagus nerve stimulation can reduce cytokine production by roughly 70%, not 100%. SetPoint treatment duration: 1 minute a day - The immunoregulation therapy device is described as requiring only one minute of daily stimulation. Clinical response in RA: about half of patients - Tracy notes that anti-TNF biologics and some VNS approaches help roughly 50% of patients in certain conditions. Sepsis and chronic disease mortality: 40 million of 60 million deaths annually - He cites WHO-scale mortality from heart disease, stroke, neurodegeneration, metabolic disease, diabetes, and cancer. Human lifespan change: 40-50 years added - He attributes major lifespan gains over the last 150 years to reduced infectious disease burden. Heart rate variability improvement: tripled HRV - Ferriss describes a friend who reportedly tripled HRV after using a vagus nerve stimulator. Clinical follow-up: 2 weeks of stimulation with 2-3 months effect - Ferriss references durable effects from stimulation lasting months after a short treatment period. Auricular stimulation study: 70% of volunteers responded - Tracy says about 7 or 8 out of 10 healthy volunteers showed reduced inflammatory cytokine production after ear stimulation. Spleen blood flow: 20% of cardiac output - Used to explain why the spleen is a major site where vagal anti-inflammatory signaling can act on circulating immune cells. Mouse vagus nerve fibers: 5,000 fibers - Compared with humans, mouse vagus nerves are much smaller, with about 5,000 fibers. Cytokine-specific engrams: TNF and IL-1 produce distinct neural networks - Tracy describes ongoing work showing different cytokines may map to different brain engrams.

Pivotal Quotes: "The brain can suppress inflammation when it's running out of control." — Kevin J. Tracy: Explaining the core mechanism behind the inflammatory reflex and the rationale for vagus nerve stimulation. "If you stimulate the fibers we were just talking about, it turns off cytokine production quite effectively." — Kevin J. Tracy: Answering Ferriss’s question about what happens to cytokines when the vagus nerve is stimulated correctly. "The question that wakes me up at 3 a.m. now is what if we could cure inflammation?" — Kevin J. Tracy: Describing the broader medical implications of controlling inflammation across major chronic diseases.

Implications: The episode suggests bioelectronic medicine may become a major treatment category for inflammatory and neuroimmune disease, but only if claims are tied to mechanism and validated in rigorous trials. It also points to a future where neural circuits, not just drugs, are used to modulate immunity, mood, pain, and recovery.

🔓 Sign Up for Unlimited Episode Search

About The Tim Ferriss Show

Tim Ferriss is a self-experimenter and bestselling author, best known for The 4-Hour Workweek. In this show, he deconstructs world-class performers from eclectic areas (investing, sports, business, art, etc.) to extract the tactics, tools, and routines you can use.

View all episodes from The Tim Ferriss Show